Roche has agreed to acquire Flatiron Health for $1.9 billion, a deal that brings the cancer research capabilities of Flatiron
Archives
Research Headlines – Tackling big data challenges in shades of grey
[Source: Research & Innovation] EU-funded researchers have assisted in the development of China’s first commercial passenger plane by applying data
ICYMI: Insights from my time with Vicki Sato at BIO CEO & Investor Conference
At this week’s BIO CEO & Investor Conference the idea of saving the “best for last” certainly did apply. I
Russian trolls flood Twitter after Parkland shooting
Without identification by Twitter or the government, it’s impossible to know who is a troll and who isn’t. A survey
Stratatech Begins Test of Engineered Skin for Diabetic Foot Ulcers
Stratatech is moving forward with tests of a genetically engineered human skin that could heal the sores and wounds many
FDA O.K.’s Banyan Diagnostic, the First Blood Test for Concussions
The FDA has approved the first blood test to help diagnose concussions, clearing a path to the market for a
2nd HBP Curriculum Workshop Series – ENTREPRENEURSHIP IN NEUROSCIENCE – TURNING SCIENCE INTO INVEN – 4-6 July 2018, Berlin, Germany
[Source: Research & Innovation] This “hackathon” style workshop is a hands-on intensive experience complementing the theoretical aspects of the online
Happy Valentine’s Day: Biotechnology is Good for the Heart
With today being Valentine’s Day and February being American Heart Month, there’s no better time to explore how biotechnology has
iShares NASDAQ Biotechnology Index (IBB) Position Increased by Evanson Asset Management LLC
iShares NASDAQ Biotechnology Index logo Evanson Asset Management LLC grew its stake in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB)
FDA’s Rachel Sherman on Right to Try, Succession Trouble & More
The opioid crisis. Right to Try legislation. The first human trials of CRISPR-Cas9 gene editing technology. These are just a